BioNTech
BNTX
BNTX
301 hedge funds and large institutions have $5.79B invested in BioNTech in 2024 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 84 increasing their positions, 86 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 294 → 301 (+7)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
2% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 86
Holders
301
Holding in Top 10
7
Calls
$373M
Puts
$269M
Top Buyers
| 1 | +$160M | |
| 2 | +$102M | |
| 3 | +$70M | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$49.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$46.3M |
Top Sellers
| 1 | -$73.7M | |
| 2 | -$43M | |
| 3 | -$29.9M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$25.1M |
| 5 |
BlackRock
New York
|
-$24.6M |